Literature DB >> 16240131

A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinase-associated neurodegeneration: evidence for a founder effect.

P Rump1, H H Lemmink, C C Verschuuren-Bemelmans, P M Grootscholten, J M Fock, S J Hayflick, S K Westaway, Y J Vos, A J van Essen.   

Abstract

Mutation analysis was performed in four apparently unrelated Dutch families with pantothenate kinase-associated neurodegeneration, formerly known as Hallervorden-Spatz syndrome. A novel 3-bp deletion encompassing the nucleotides GAG at positions 1,142 to 1,144 of exon 5 of the PANK2 gene was found in all patients. One patient was compound heterozygous; she also carried a novel nonsense mutation (Ser68Stop). The other patients were homozygous for the 1142_1144delGAG mutation. The 1142_1144delGAG mutation was also found in a German patient of unknown descent. We used polymorphic microsatellite markers flanking the PANK2 gene (spanning a region of approximately 8 cM) for haplotype analyses in all these families. A conserved haplotype of 1.5 cM was found for the 1142_1144delGAG mutation carriers. All the Dutch families originated from the same geographical region within the Netherlands. The results indicate a founder effect and suggest that the 1142_1144delGAG mutation probably originated from one common ancestor. It was estimated that this mutation arose at the beginning of the ninth century, approximately 38 generations ago.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16240131      PMCID: PMC2105745          DOI: 10.1007/s10048-005-0018-9

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  27 in total

1.  The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.

Authors:  A Bergman; Z Einbeigi; U Olofsson; Z Taib; A Wallgren; P Karlsson; J Wahlström; T Martinsson; M Nordling
Journal:  Eur J Hum Genet       Date:  2001-10       Impact factor: 4.246

2.  Hallervorden Spatz syndrome (pantothenate kinase associated neurodegeneration) in two Sardinian brother with homozygous mutation in PANK 2 gene.

Authors:  Giovanni Cossu; Maurizio Melis; Gianluca Floris; Susan J Hayflick; Andrea Spissu
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

3.  Canadian Mennonites and individuals residing in the Friesland region of The Netherlands share the same molecular basis of 17 alpha-hydroxylase deficiency.

Authors:  T Imai; T Yanase; M R Waterman; E R Simpson; J J Pratt
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

4.  Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.

Authors:  K D Sethi; R J Adams; D W Loring; T el Gammal
Journal:  Ann Neurol       Date:  1988-11       Impact factor: 10.422

5.  New estimates of intergenerational time intervals for the calculation of age and origins of mutations.

Authors:  M Tremblay; H Vézina
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

6.  Intrafamilial phenotypic variability of Hallervorden-Spätz syndrome in a Tunisian family.

Authors: 
Journal:  Parkinsonism Relat Disord       Date:  2000-07-01       Impact factor: 4.891

7.  The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration.

Authors:  M T Pellecchia; E M Valente; L Cif; S Salvi; A Albanese; V Scarano; U Bonuccelli; A R Bentivoglio; A D'Amico; C Marelli; A Di Giorgio; P Coubes; P Barone; B Dallapiccola
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

8.  An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria.

Authors:  Konstanze Hörtnagel; Holger Prokisch; Thomas Meitinger
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

9.  Pure akinesia: an unusual phenotype of Hallervorden-Spatz syndrome.

Authors:  José L Molinuevo; María J Martí; Rafael Blesa; Eduardo Tolosa
Journal:  Mov Disord       Date:  2003-11       Impact factor: 10.338

10.  Perspectives of identity by descent (IBD) mapping in founder populations.

Authors:  G J Te Meerman; M A Van der Meulen; L A Sandkuijl
Journal:  Clin Exp Allergy       Date:  1995-11       Impact factor: 5.018

View more
  5 in total

Review 1.  Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.

Authors:  Manju A Kurian; Susan J Hayflick
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

2.  Panthotenate Kinase-Associated Neurodegeneration Has a Founder Mutation (c.215_216insa) in Indian Agrawal Patients.

Authors:  Vrajesh Udani; Soma Das; Rahul Chhabria
Journal:  Mov Disord Clin Pract       Date:  2016-04-05

3.  A variation in PANK2 gene is causing Pantothenate kinase-associated Neurodegeneration in a family from Jammu and Kashmir - India.

Authors:  Arshia Angural; Inderpal Singh; Ankit Mahajan; Pranav Pandoh; Manoj K Dhar; Sanjana Kaul; Vijeshwar Verma; Ekta Rai; Sushil Razdan; Kamal Kishore Pandita; Swarkar Sharma
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

4.  Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.

Authors:  Daniel Elbaum; Maria G Beconi; Edith Monteagudo; Annalise Di Marco; Maria S Quinton; Kathryn A Lyons; Andrew Vaino; Steven Harper
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

5.  Novel PANK2 Mutations in Patients With Pantothenate Kinase-Associated Neurodegeneration and the Genotype-Phenotype Correlation.

Authors:  Wen-Bin Li; Nan-Xiang Shen; Chao Zhang; Huan-Cheng Xie; Zong-Yan Li; Li Cao; Li-Zhi Chen; Yuan-Jin Zeng; Cui-Xia Fan; Qian Chen; Yi-Wu Shi; Xing-Wang Song
Journal:  Front Aging Neurosci       Date:  2022-04-06       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.